Keywords: Merck & Co, Investor law suit, Teva, Protonix, Potential damages

Merck & Co to pay $688 million to settle investor law suits; Teva could face $2.1 billion damages

Article | 15 February 2013

Print This

US pharma giant Merck & Co (NYSE: MRK) said yesterday that it has reached an agreement in principle with plaintiffs ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in